Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;82(2):e36-e39.
doi: 10.1016/j.jinf.2020.08.017. Epub 2020 Aug 14.

Medical features of COVID-19 and influenza infection: A comparative study in Paris, France

Affiliations
Comment

Medical features of COVID-19 and influenza infection: A comparative study in Paris, France

Hélène Faury et al. J Infect. 2021 Feb.
No abstract available

Keywords: COVID-19; Influenza; References: 10; Risk factors; Severe clinical forms.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest We declare no competing interests.

Figures

Fig 1
Fig. 1
Duration from illness onset and clinical courses in COVID-19 (n = 100) and influenza groups (n = 100) Histograms represent duration in days of symptoms before admission (blue), stay out of ICU (light pink), stay in ICU for severe cases (red), and in post-ICU supportive care wards (yellow). n represent the number of concerned patients according to type of hospitalization. The median time from illness onset (i.e. before admission) to admission was 4 days [IQR: 1–6] and 2 days [IQR: 0–4] for COVID-19 and influenza patients, respectively (p = 0.02). The median time of hospitalization out of ICU was 5 days [IQR: 1–10] and 1 day [IQR: 0–8] for COVID-19 and influenza patients, respectively (p = 0.0112). Overall, 20 and 5 patients died in both groups, respectively. Among ICU-hospitalized patients (31 COVID-19 and 12 influenza), 11 and 3 patients died in both groups, respectively. * symbolizes significant differences between COVID-19 and influenza groups. COVID-19: coronavirus disease 2019; ICU: intensive care unit. p<0.05 was considered to be statistically significant.

Comment on

References

    1. Zheng X., Wang H., Su Z. Co-infection of SARS-CoV-2 and influenza virus in early stage of the COVID-19 epidemic in Wuhan. China J Infect. 2020;81(2):e128–e129. doi: 10.1016/j.jinf.2020.05.041. - DOI - PMC - PubMed
    1. Kissler Stephen M., Christine Tedijanto, Edward Goldstein, Grad Yonatan H., Marc Lipsitch. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):860–868. doi: 10.1126/science.abb5793. - DOI - PMC - PubMed
    1. Safiya Richardson, Hirsch Jamie S., Mangala Narasimhan, Crawford James M., McGinn Thomas, Davidson Karina W. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020 doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Lu Lin, Xiayang Jiang, Zhenling Zhang, Siwen Huang, Zhenyi Zhang, Zhaoxiong Fang. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997–1001. doi: 10.1136/gutjnl-2020-321013. - DOI - PubMed
    1. Changxing Shen, Min Tan, Xiaolian Song, Guoliang Zhang, Jiren Liang, Hong Yu. Comparative analysis of early-stage clinical features between COVID-19 and influenza A H1N1 virus pneumonia. Front Public Health. 2020;8:206. doi: 10.3389/fpubh.2020.00206. - DOI - PMC - PubMed